Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.34
+0.02 (0.15%)
At close: Apr 29, 2026, 4:00 PM EDT
13.24
-0.10 (-0.74%)
After-hours: Apr 29, 2026, 6:41 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.50 billion as of April 29, 2026. Its market cap has increased by 21.47% in one year.
Market Cap
3.50B
Enterprise Value
11.72B
1-Year Change
21.47%
Ranking
Category
Stock Price
$13.34
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.50B, a decrease of -58.38%. That is a compound annual growth rate of -16.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.50B | 87.64% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 184.25B |
| Amgen | 182.19B |
| Gilead Sciences | 160.20B |
| Pfizer | 149.60B |
| Bristol-Myers Squibb Company | 118.50B |
| Sanofi | 111.55B |
| GSK plc | 109.34B |
| Biogen | 28.07B |